21 CFR § 520.1367 - Meloxicam.

---
identifier: "/us/cfr/t21/s520.1367"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 520.1367 - Meloxicam."
title_number: 21
title_name: "Food and Drugs"
section_number: "520.1367"
section_name: "Meloxicam."
chapter_name: "FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "E"
subchapter_name: "ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS"
part_number: "520"
part_name: "ORAL DOSAGE FORM NEW ANIMAL DRUGS"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "21 U.S.C. 360b."
regulatory_source: "40 FR 13838, Mar. 27, 1975, unless otherwise noted."
cfr_part: "520"
---


# 520.1367 Meloxicam.

(a) *Specifications*—(1) Each milliliter of suspension contains 0.5 milligrams (mg) meloxicam.

(2) Each milliliter of suspension contains 1.5 mg meloxicam.

(b) *Sponsors.* See sponsors in § 510.600(c) of this chapter for uses as in paragraph (c) of this section:

(1) Nos. 000010 and 069043 for use of the products described in paragraph (a) of this section; and

(2) Nos. 013744, 055529, and 086101 for use of the product described in paragraph (a)(2) of this section.

(c) *Conditions of use in dogs*—(1) *Amount.* Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on the first day of treatment. For all treatments after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.

(2) *Indications for use.* For the control of pain and inflammation associated with osteoarthritis.

(3) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.

[68 FR 42968, July 21, 2003, as amended at 69 FR 69523, Nov. 30, 2004. Redesignated and amended at 78 FR 57058, Sept. 17, 2013; 80 FR 53459, Sept. 4, 2015; 91 FR 5301, Feb. 6, 2026]